Restricted accessResearch articleFirst published online 2013-10
Exacerbation of Obsessive-Compulsive Disorder,Generalized Anxiety Disorder,and Chronic Motor Tics During Treatment of Attention-Deficit/Hyperactivity Disorder: Medication Management in an Older Adolescent
AntshelKM, FaraoneSV, GordonM. cognitive behavioral treatment outcomes in adolescent ADHD. J Atten Disord[Epub ahead of print]2012.
2.
BlochMH, PanzaKE, Landeros-WeisenbergerA, LeckmanJF. Meta-analysis: Treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry, 48:884–893. 2009.
3.
BrinkmanWB, ShermanSN, ZmitrovichAR, VisscherMO, CrosbyLE, PhelanKJ, DonovanEF. In their own words: Adolescent views on ADHD and their evolving role managing medication. Acad Pediatr, 12:53–61. 2012.
4.
de MathisMA, DinizJB, HounieAG, ShavittRG, FossaluzaV, FerrãoY, LeckmanJF, de Bragança PereiraC, do RosarioMC, MiguelEC. Trajectory in obsessive-compulsive disorder comorbidities. Eur Neuropsychopharmacol, 23:594–601. 2013.
5.
FranklinME, SapytaJ, FreemanJB, KhannaM, ComptonS, AlmirallD, MooreP, Choate-SummersM, GarciaA, EdsonAL, FoaEB, MarchJS. Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: The Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. JAMA, 306:1224–1232. 2011.
6.
Gomes de AlvarengaP, de MathisMA, Dominguez AlvesAC, do RosárioMC, FossaluzaV, HounieAG, MiguelEC, Rodrigues TorresA. Clinical features of tic-related obsessive-compulsive disorder: Results from a large multicenter study. CNS Spectr, 17:87–93. 2012.
7.
GormanDA, ThompsonN, PlessenKJ, RobertsonMM, LeckmanJF, PetersonBS. Psychosocial outcome and psychiatric comorbidity in older adolescents with Tourette syndrome: Controlled study. Br J Psychiatry, 197:36–44. 2010.
8.
HoughtonS, AlsalmiN, TanC, TaylorM, DurkinK. Treating comorbid anxiety in adolescents with ADHD using a cognitive behavior therapy program approach. J Atten Disord[Epub ahead of print]2013.
9.
LachaineJ, BeaucheminC, SasaneR, HodgkinsPS. Treatment patterns, adherence, and persistence in ADHD: A Canadian perspective. Postgrad Med, 3:139–148. 2012.
10.
MontanoCB, YoungJ. Discontinuity in the transition from pediatric to adult health care for patients with attention-deficit/hyperactivitydisorder. Postgrad Med, 124:23–32. 2012.
11.
PelhamWE, SmithBH, EvansSW, BuksteinO, GnagyEM, GreinerAR, SibleyMH. The effectiveness of short-, long-acting stimulant medications for adolescents with ADHD in a naturalistic secondary school setting. J Atten Disord.[Epub ahead of print]2013.
12.
PhilipsenA. Psychotherapy in adult attention deficit hyperactivity disorder: Implications for treatment and research. Expert Rev Neurother, 10:1217–1225. 2012.
13.
PringsheimT, SteevesT. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders. Cochrane Database Syst Rev., 13. 2011.
14.
RothenbergerA, DöpfnerM. Observational studies in ADHD: The effects of switching to modified-release methylphenidate preparations on clinical outcomes and adherence. Eur Child Adolesc Psychiatry., 20:S235–242. 2011.
15.
SetyawanJ, HodgkinsP, GuérinA, GauthierG, CloutierM, WuEQ, ErderMH. Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: A retrospective analysis. J Med Econ, 7:962–975. 2013.
16.
StewartSE, HezelD, StachonAC. Assessment and medication management of paediatric obsessive-compulsive disorder. Drugs, 72:881–893. 2012.
17.
ToomeySL, SoxCM, RusinakD, FinkelsteinJA. Why do children with ADHD discontinue their medication?Clin Pediatr, 51:763–769. 2012.
